Fate Therapeutics(FATE) - 2023 Q2 - Earnings Call Transcript

Fate Therapeutics, Inc. (NASDAQ:FATE) Q2 2023 Earnings Conference Call August 8, 2023 5:00 PM ET Company Participants Scott Wolchko - President & Chief Executive Officer Ed Dulac - Chief Financial Officer Bob Valamehr - Chief Research & Development Officer Conference Call Participants Jack Allen - Baird Operator Welcome to the Fate Therapeutics Second Quarter 2023 Financial Results Conference Call. At this time, all participants are in listen-only mode. This call is being webcast live on the Investors secti ...